➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Baxter
Colorcon
Johnson and Johnson

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEOXYCHOLIC ACID

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Deoxycholic Acid

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00422188 ↗ Deoxycholic Acid Injection for the Treatment of Superficial Lipomas Completed Kythera Biopharmaceuticals Phase 1 2007-01-01 The purpose of this research is to compare the safety and effectiveness of 4 different concentrations of deoxycholic acid injection against a placebo in the treatment of superficial lipomas.
NCT00608842 ↗ Phase 2 Study for the Treatment of Superficial Lipomas Completed Kythera Biopharmaceuticals Phase 2 2007-11-01 The purpose of this research is to compare the safety and effectiveness of 3 different concentrations of deoxycholic acid for injection against a placebo in the treatment of superficial lipomas.
NCT00618618 ↗ Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Completed Kythera Biopharmaceuticals Phase 2 2008-04-01 Phase 2 trial to evaluate the safety and potential efficacy of one concentration of deoxycholic acid injection, given in three dosing paradigms, compared to placebo for the reduction of submental fat (fat beneath the chin).
NCT00618722 ↗ Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Completed Kythera Biopharmaceuticals Phase 1/Phase 2 2007-08-01 To evaluate the safety and potential efficacy of deoxycholic acid injection compared to placebo for the reduction of submental fat (fat below the chin).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Deoxycholic Acid

Condition Name

Condition Name for Deoxycholic Acid
Intervention Trials
Moderate or Severe Submental Fullness 9
Submental Fat 3
Lipoma 2
Healthy Volunteers 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Deoxycholic Acid
Intervention Trials
Lipoma 2
Diarrhea 1
Gastroesophageal Reflux 1
Barrett Esophagus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Deoxycholic Acid

Trials by Country

Trials by Country for Deoxycholic Acid
Location Trials
United States 87
Canada 10
United Kingdom 5
Germany 3
Australia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Deoxycholic Acid
Location Trials
California 10
New York 7
Florida 6
Illinois 6
Texas 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Deoxycholic Acid

Clinical Trial Phase

Clinical Trial Phase for Deoxycholic Acid
Clinical Trial Phase Trials
Phase 4 1
Phase 3 9
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Deoxycholic Acid
Clinical Trial Phase Trials
Completed 15
Recruiting 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Deoxycholic Acid

Sponsor Name

Sponsor Name for Deoxycholic Acid
Sponsor Trials
Kythera Biopharmaceuticals 14
Bayer 2
Allergan 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Deoxycholic Acid
Sponsor Trials
Industry 17
Other 4
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
Harvard Business School
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.